MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET 2021-2028
1. MIDDLE EAST AND AFRICA BOTULINUM
TOXIN MARKET – SUMMARY
2. INDUSTRY OUTLOOK
1.1. KEY INSIGHTS
1.1.1. SURGE IN DISPOSABLE INCOME
1.1.2. GROWING NUMBER OF MEN OPTING FOR
COSMETIC TREATMENT
1.1.3. DEVELOPMENT OF HEALTHCARE
INFRASTRUCTURE
1.1. IMPACT OF COVID-19 ON THE BOTULINUM
TOXIN INDUSTRY
1.2. PORTER’S FIVE FORCES ANALYSIS
1.1.1. THREAT OF NEW ENTRANTS
1.1.2. THREAT OF SUBSTITUTE
1.1.3. BARGAINING POWER OF SUPPLIERS
1.1.4. BARGAINING POWER OF BUYERS
1.1.5. THREAT OF COMPETITIVE RIVALRY
1.1. MARKET ATTRACTIVENESS MATRIX
1.2. VENDOR SCORECARD
1.3. KEY MARKET STRATEGIES
1.1.1. NEW PRODUCT LAUNCHES
1.1. MARKET DRIVERS
1.1.1. INCREASING DEMAND FOR AESTHETIC
PROCEDURES
1.1.2. EXPANSION OF BOTULINUM TOXIN INTO
THERAPEUTIC APPLICATIONS
1.1. MARKET RESTRAINTS
1.1.1. ADVERSE EFFECTS ASSOCIATED WITH
BOTULINUM TOXIN
1.1.2. LACK OF REIMBURSEMENT POLICIES
SUPPORTING COSMETIC PROCEDURES
1.1.3. LACK OF INTERCHANGEABILITY BETWEEN
BOTULINUM TOXIN PRODUCTS
1.1. MARKET OPPORTUNITIES
1.1.1. INCREASING AGING POPULATION
1.1.2. RISE IN MEDICAL TOURISM
2. MIDDLE EAST AND AFRICA BOTULINUM
TOXIN MARKET – BY TYPE
1.1. TYPE A
1.2. TYPE B
2. MIDDLE EAST AND AFRICA BOTULINUM
TOXIN MARKET – BY APPLICATION
1.1. COSMETIC APPLICATIONS
1.1.1. GLABELLAR LINES
1.1.2. LATERAL CANTHAL LINES (CROW’S FEET)
1.1.3. FOREHEAD LINES
1.1.4. OTHER COSMETIC APPLICATIONS
1.1. NON-COSMETIC APPLICATIONS
1.1.1. DYSTONIA
1.1.2. CHRONIC MIGRAINE
1.1.3. OPHTHALMOLOGIC DISORDERS
1.1.4. OTHER NON-COSMETIC APPLICATIONS
1. MIDDLE EAST AND AFRICA BOTULINUM
TOXIN MARKET – BY END-USER
1.1. HOSPITALS
1.2. CLINICS AND OTHERS
2. MIDDLE EAST AND AFRICA BOTULINUM
TOXIN MARKET – REGIONAL OUTLOOK
1.1. COUNTRY ANALYSIS
1.1.1. UNITED ARAB EMIRATES
1.1.2. TURKEY
1.1.3. SAUDI ARABIA
1.1.4. SOUTH AFRICA
1.1.5. REST OF MIDDLE EAST & AFRICA
2. COMPETITIVE LANDSCAPE
1.1. ABBVIE INC
1.2. EVOLUS INC
1.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
1.4. HUGEL INC
1.5. IPSEN PHARMA
1.6. MERZ PHARMA
1.7. MEDYTOX INC
1.8. REVANCE THERAPEUTICS INC
1.9. US WORLDMEDS LLC
2. METHODOLOGY & SCOPE
1.1. RESEARCH SCOPE & DELIVERABLES
1.2. SOURCES OF DATA
1.3.
RESEARCH METHODOLOGY
LIST OF TABLES
TABLE 1: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF NEW PRODUCT LAUNCHES
TABLE 5: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION,
2021-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COSMETIC
APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC
APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY END-USER,
2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE, 2020
& 2028
FIGURE 3: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE A,
2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE B,
2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION,
2020 & 2028
FIGURE 6: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS,
2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY GLABELLAR
LINES, 2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY LATERAL
CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY FOREHEAD
LINES, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY OTHER
COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY
NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY DYSTONIA,
2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY CHRONIC
MIGRAINE, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA BOTULINUM
TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY OTHER
NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY END-USER,
2020 & 2028
FIGURE 17: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY HOSPITALS,
2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY CLINICS AND
OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, REGIONAL
OUTLOOK, 2020 & 2028 (IN %)
FIGURE 20: UNITED ARAB EMIRATES BOTULINUM TOXIN MARKET 2021-2028 (IN $
MILLION)
FIGURE 21: TURKEY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: SAUDI ARABIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: SOUTH AFRICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET
2021-2028 (IN $ MILLION)
MARKET OUTLOOK
Triton’s report on the Middle East and Africa’s botulinum toxin market
states that this industry would grow with a CAGR of 5.42% in the forecast years
2021-2028. The United Arab Emirates, Turkey, South Africa, Saudi Arabia, and
Rest of MEA together shape the market in this region.
People in Turkey are increasingly spending on their appearance, in order
to look well-groomed, attractive, and young. The beauty & aesthetics
industry in the country has grown steadily in the last couple of years.
With the growing awareness and popularity of before-and-after pictures,
a large number of people are seeking cosmetic & beauty treatments. Turkey
attracts several patients from different countries every year, thanks to the
high standard of treatments offered, the well-developed infrastructure, and
affordable prices. Recent statistics show a rising trend in both males and
females.
In fact, the country is now being counted among the top ten tourism
destinations for cosmetic and aesthetic procedures in the world. Although the
number of medical tourists seeking treatments in ophthalmology, obstetrics
& gynecology, and orthopedics is appreciable, the demand for aesthetic and
cosmetic procedures remains a few notches high. All these factors have boosted
the demand for botulinum toxin. This growing demand is expected to propel the
studied market on a growth path in the forthcoming years.
COMPETITIVE OUTLOOK
The major organizations that have established their presence in the
botulinum toxin market are Revance Therapeutics Inc, Ipsen Pharma, Galderma
Pharma SA (Acquired By EQT), Abbvie Inc (Allergan Plc), and Hugel Inc.
Get more insights into the Middle East Africa Botulinum Toxin Market:
https://www.tritonmarketresearch.com/reports/middle-east-and-africa-botulinum-toxin-market
SEGMENTATION
1. ABBVIE INC
2. EVOLUS INC
3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
4. HUGEL INC
5. IPSEN PHARMA
6. MERZ PHARMA
7. MEDYTOX INC
8. REVANCE THERAPEUTICS INC
9.
US WORLDMEDS LLC
Comments
Post a Comment